Article
Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin.
Journal of translational medicine - 10 May 2016
Hall Jason C, Marlow Laura A, Mathias Adam C, Dawson Louis K, Durham William F, Meshaw Kenneth A, Mullin Robert J, Synnott Aidan J, Small Daniel L, Krishna Murli, von Hoff Daniel, Schüler Julia, Hart Steven N, Couch Fergus J, Colon-Otero Gerardo, Copland John A
Abstract excerpt
BACKGROUND: Pancreatic acinar cell carcinoma (PACC) is a rare malignancy, accounting for <1 % of all pancreatic neoplasms. Very few retrospective studies are available to help guide management. We previously reported the case of a patient with metastatic PACC who achieved prolonged survival following doxorubicin treatment. Personalized treatment was based on molecular and in vitro data collected from primary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
